Sia Daneshmand

Associate Professor of Urology (Clinical Scholar) Director of Urologic Oncology, USC Institute of Urology

Areas of treatment:

Bladder Cancer
Testis Cancer
Kidney Cancer
Vena Caval Tumor Thrombus
Prostate Cancer
Urinary Tract Reconstruction (Neobladder and Continent Cutaneous Diversion)
Retroperitoneal Sarcoma
Radical Cystectomy
Nerve Sparing Post Chemo Retroperitoneal Lymph Node Dissection (RPLND)


  • Urology


  • Department of Urology


  • English
  • Persian
  • Spanish
best doctor

Sia Daneshmand, MD

Associate Professor of Urology (Clinical Scholar)
Director of Urologic Oncology, USC Institute of Urology

Practicing locations:

  • Keck Hospital of USC
  • USC Norris Comprehensive Cancer Center and Hospital

About this doctor:

Dr. Sia Daneshmand earned his medical degree at the University of California, Davis and completed his residency at the University of Southern California (USC) followed by a two-year fellowship in Urologic Oncology at the USC Norris Comprehensive Cancer Center. He spent almost six years at Oregon Health and Science University where he established the Section of Urologic Oncology as a center of excellence for treatment of bladder and testis cancers. He was recruited to USC Institute of Urology in 2010 as Director of Urologic Oncology. He is currently an associate professor of urology with clinical scholar designation and serves as director of clinical research as well as the urologic oncology fellowship director. Dr. Daneshmand’s main interests include bladder cancer, advanced kidney cancer and testicular cancer. He has extensive experience in urinary diversion and reconstruction following surgical removal of the bladder (radical cystectomy) as well as nerve-sparing retroperitoneal lymph node dissection (RPLND) following chemotherapy for advanced testis cancer. He is one of the highest volume surgeons for this disease on the west coast. He has been selected as one of “True Experts” in the Testicular Cancer Resource Center web site. He also has extensive experience in the management of advanced kidney cancers with vena caval tumor thrombus involvement, as well as prostate cancer, retroperitoneal sarcomas and surgeries requiring replacement of the great vessels. He is a member of Alpha Omega Alpha medical honor society, and has been designated one of the “America’s Top Doctors” for several years. He is an active member of the Society of Urologic Oncology, has presented over 150 abstracts at scientific meetings and has authored over 120 peer-reviewed articles, reviews, and chapters. He is a reviewer for numerous urology journals.


Doctor of Medicine, University of California, Davis, 1996


LAC+USC Medical Center, Surgery, 1996 - 1997


LAC+USC Medical Center, Urology, 1997 - 2002


USC Department of Urology, Urological Oncology, 2002 - 2004


American Board of Urology

Professional society memberships:

American Urologic Association
Western Section of the American Urologic Association (Board of Directors 2008 - 2010)
Society of Urologic Oncology
Southwest Oncology Group
Northwest Urologic Society (Program Chair, NWUS Meeting 2008)


Alpha Omega Alpha Honor Medical Society
America's Top Doctors, 2009
America's Top Cancer Doctors, 2009
America's Top Urologists, 2008 - 2009
Portland's Monthly Top Doctors, 2007, 2010
Testis Cancer Resource Center (web site) - True Experts List. Hadley Award, 2005 Western Section AUA Meeting. Intraoperative Caval Tumor Thrombus Embolization To The Right Atrium- Incidental Diagnosis By Transesophageal Echocardiography
1st Place- Best of Poster Session. 2004 Western Section AUA Meeting. Ethnic Differences in Neuroendocrine Cell Distribution in Normal Human Prostatic Tissue
2011 list of America's Top Doctors, compiled by Castle Connolly Medical Ltd.
Castle Connolly "Top Doctor,” 2015